Barriers and enablers to diabetic eye screening: a cross sectional survey of young adults with type 1 and type 2 diabetes in the UK - Prothero, Louise; Cartwright, Martin; Lorencatto, Fabiana; Burr, Jennifer M; Anderson, John; Gardner, Philip; Presseau, Justin; Ivers, Noah; Grimshaw, Jeremy M; Lawrenson, John G; the EROS Study Investigators (medRxiv, 2022)
Introduction Diabetic retinopathy screening (DRS) attendance in young adults is consistently below recommended levels. The aim of this study was to identify barriers and enablers of diabetic retinopathy screening (DRS) attendance amongst young adults (YA) in the UK living with type 1 (T1D) and type 2 (T2D) diabetes.Research design and methods YAs (18-34yrs) were invited to complete an anonymous online survey in June 2021 assessing agreement with 30 belief statements informed by the Theoretical Domains Framework of behaviour change (TDF) describing potential barriers/enablers to DRS.Results In total 102 responses were received. Most had T1D (65.7%) and were regular attenders for DRS (76.5%). The most salient TDF domains for DRS attendance were ‘Goals’, with 93% agreeing that DRS was a high priority and ‘Knowledge’, with 98% being aware that screening can detect eye problems early.Overall 67.4% indicated that they would like greater appointment flexibility [Environmental context/resources] and 31.3% reported difficulties getting time off work/study to attend appointments [Environmental Context/Resources]. This was more commonly reported by occasional non-attenders versus regular attenders (59.1% vs 23.4%, P=0.002) Most YAs were worried about diabetic retinopathy (74.3%), anxious when receiving screening results (63%) [Emotion] and would like more support after getting their results (66%) [Social influences]. Responses for T1D and T2D were broadly similar, although those with T2D were more likely have developed strategies to help them to remember their appointments (63.6% vs 37.9%, P=0.019) [Behavioural regulation].Conclusions Attendance for DRS in YAs is influenced by complex interacting behavioural factors. Identifying modifiable determinants of behaviour will provide a basis for designing tailored interventions to improve DRS in YAs and prevent avoidable vision loss.What is already known about this subject?Younger adults (<35 years) with diabetes have been identified as having longer time intervals before attending initial diabetic retinopathy screening (DRS) and are more likely to miss successive screening appointments.Previous studies have explored modifiable influences on DRS attendance, but often do not differentiate between population groups, particularly young adults.What are the new findings?One of the main reported barriers to attending DRS was the lack of appointment flexibility and difficulty getting time off work/study to attend appointments. This was compounded by the lack of integration of DRS with other diabetes appointments.Most young adults were worried about diabetic retinopathy, anxious when receiving screening results and would like more supportHow might these results change the focus of research or clinical practice?A more tailored approach is needed to support young adults to attend DRS. The findings of this research provide a basis for developing tailored interventions to increase screening uptake in this age groupCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis report is independent research funded by the National Institute for Health Research (Policy Research Programme, Enabling diabetic RetinOpathy Screening: Mixed methods study of barriers and enablers to attendance (EROS study), PR-R20-0318-22001). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received ethical approval from the NHS Wales Research Ethics Committee 2 (REC reference: 19/WA/0228). Prior informed consent was obtained from all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors